Safety of nevirapine compared to abacavir on a background of zidovudine/lamivudine as first-line antiretroviral therapy: a randomised double-blind trial conducted in Uganda.

Citation

13th Conference on Retroviruses and Opportunistic Infections, Denver, USA, 5-9 February 2006: Abstract 109LB.

Safety of nevirapine compared to abacavir on a background of zidovudine/lamivudine as first-line antiretroviral therapy: a randomised double-blind trial conducted in Uganda.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.